Arlington Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25
Closed -$4.21K 630
2023
Q1
$4.21K Buy
+25
New +$4.46K ﹤0.01% 472
2022
Q2
Sell
-170
Closed -$32K 491
2022
Q1
$32K Sell
170
-285
-63% -$54.1K 0.01% 283
2021
Q4
$121K Sell
455
-102
-18% -$27.5K 0.03% 172
2021
Q3
$161K Buy
+557
New +$143K 0.05% 128

Other funds holding RGEN

Arlington Partners's RGEN Position: Q2 2023 in Review

Arlington Partners sold out of Repligen (RGEN) in Q2 2023, closing a stake of 25 shares — an estimated $4.21K sold.

Arlington Partners first reported a position in RGEN in Q3 2021 and held it in 4 quarters. The position peaked at $161K in Q3 2021. 447 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Arlington Partners reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Arlington Partners sold 25 Repligen shares in Q2 2023, an estimated $4.21K.
  • Arlington Partners first reported a position in Repligen in Q3 2021 and held it in 4 quarters.
  • Arlington Partners's Repligen position peaked at $161K in Q3 2021.
  • 447 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Arlington Partners's 13F filing for Q2 2023, filed 26 Jul 2023.